SCHEMBL30657804

SCHEMBL30657804

CC(C)(C)OC(=O)NC1CCN(C(=O)c2ccccc2N)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.57
NAMPT P43490 1/20 0.56
KCNA3 P22001 1/20 0.51
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
CKS1B P61024 1/20 0.47
SKP1 P63208 1/20 0.47
SKP2 Q13309 1/20 0.47
HSD11B1 P28845 1/20 0.47
MGLL Q99685 1/20 0.47
DRD2 P14416 2/20 0.47
MERTK Q12866 1/20 0.47
KDM1A O60341 1/20 0.46
MAOB P27338 1/20 0.46
CTSK P43235 2/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30657815 0.89 PARP1 (0.52) PARP1NAMPTKCNA3HDAC3HDAC1
SCHEMBL4616517 0.83 NAMPT (0.69) PARP1NAMPTKCNA3CKS1BSKP1
SCHEMBL30657812 0.82 HTT (0.54) PARP1NAMPTKCNA3CKS1BSKP1
SCHEMBL29979363 0.81 NAMPT (0.65) PARP1NAMPTKCNA3HDAC3HDAC1
SCHEMBL1271996 0.81 CKS1B (0.55) PARP1NAMPTKCNA3HDAC3HDAC1
SCHEMBL4960694 0.81 POLB (0.58) PARP1POLBKMT2AL3MBTL1MEN1
SCHEMBL12644375 0.81 NAMPT (0.70) PARP1NAMPTKCNA3CKS1BSKP1
SCHEMBL26641094 0.81 POLB (0.55) HSD11B1MGLLPOLBKMT2AL3MBTL1
SCHEMBL31267085 0.81 PARP1 (0.53) PARP1NAMPTKCNA3HDAC3HDAC1
SCHEMBL4700826 0.81 PARP1 (0.50) PARP1NAMPTKCNA3HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260103458-A1 Inhibitors of CDK8 and CDK19 UNIV DUNDEE (GB) 2026-04-16 US disclosed
EP-4519258-A1 INHIBITORS OF CDK8 AND CDK19 University of Dundee (GB) 2025-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103458-A1 Inhibitors of CDK8 and CDK19 CDK8, CDK18, CDK9 PARP1 785/4885NAMPT 3017/4885KCNA3 3466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.